Healthcare on the Rocks · 2024-04-14 · 39 min
In this episode of "Healthcare on the Rocks: Employee Benefits with a Twist," Scott Vold, the Chief Commercial Officer at Renalogic , describes the complexities of kidney disease, its treatment, and the economic impact on employers and their health plans. Scott talks about the critical and often overlooked public health crisis of chronic kidney disease (CKD) and the intricacies of the dialysis market. With a background in health technology and actuary, Scott explains Renalogic's mission to manage both the human and financial costs of CKD for self-funded health plans. He shares eye-opening statistics, such as the fact that about 37 million adult Americans have CKD, with a staggering 90% unaware of their condition, highlighting the disease's silent proliferation and its ranking as the ninth-leading cause of death in the U.S., projected to rise to fifth by 2040. The discussion also covers the evolution of the dialysis market into a duopoly, which has led to inflated costs for treatments, emphasizing the need for a strategic approach to healthcare management within self-funded health plans.
Moving Beyond Pain: Tackling MSK Conditions with Micro-Wellness57 / 100Decoding the Fine Print: How Hi Neo Makes Healthcare Make Sense68 / 100Innovating Radiology Access: OneImaging’s Blueprint for Healthcare Savings74 / 100Breaking the Silence: Why Menopause Matters in the Workplace77 / 100Gut Check: Why GI Conditions Are Skyrocketing in Employer Healthcare Costs